CD274 and neoplasm: Chemotherapy has been recognized to favorably alter the immune TME in several ways: it increases immunogenic cell death [49], it improves dendritic cell maturation [50], it reduces the presence of immunosuppressive cells [51], it alters the expression of PD-L1 [52], and it increases the number of tumor-infiltrating lymphocytes [53].